CEO: Amit Etkin
Visit Website

Alto Neuroscience is developing a new generation of biomarker-based diagnostic tests and personalized treatments for use in mental health, based on a platform built from data aggregated at scale and proprietary artificial intelligence analysis tools.

Their goals include being able to define actionable subtypes of psychiatric illnesses, to inform the development and deployment of new treatments, and to help determine which patient will benefit from a specific treatment.

The team combines world-leading neuroscientists and business executives with experience commercializing products for the brain.